Related Experiment Video
Updated: Jul 31, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
The search for new triazole antifungal agents
1Millennium Pharmaceuticals Inc, Division of Molecular and Cellular Biology, 640 Memorial Drive, Cambridge, MA 02139, USA. koltin@mpi.com
Abstract:
The first generation antifungal agent triazoles, fluconazole and itraconazole, have revolutionised the treatment of serious fungal infections such as mucosal and invasive candidiasis and cryptococcal meningitis. However, the treatment of some fungal infections, particularly aspergillosis, is still far from satisfactory and thus there is an important requirement for new broad-spectrum antifungal agents. The new second generation triazoles voriconazole and SCH-56592 show considerable promise in achieving this goal in the near future.
More Related Videos
Related Concept Videos
Fungal Phylum Microsporidia
Candidiasis
Antiviral Nucleoside Inhibitors
Antifungal Agents
Anthelminthic Agents
Antiprotozoal Agents

